Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bon Natural LifeBON -0.87%42 12-1 Month Momentum % is -15.94% as of Aug. 22, 2026. GuruFocus rates BON with a GF Score™ of 42/100 and a GF Value™ of $0.75 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 1,613 Chemicals companies, Bon Natural Life ranks worse than 57.59% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-22), Bon Natural Life's 12-1 Month Momentum % is -15.94%.
The industry rank for Bon Natural Life's 12-1 Month Momentum % or its related term are showing as below:
BON's 12-1 Month Momentum % is ranked worse than 57.59% of 1613
companies
in the Chemicals industry
Industry Median: -5.18
vs BON: -15.94
Bon Natural Life (NAS:BON) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Bon Natural Life 12-1 Month Momentum % Related Terms
BON vs SNES, YMAT, GLGI: 12-1 Month Momentum % Comparison
For the Specialty Chemicals subindustry, Bon Natural Life's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life 12-1 Month Momentum % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's 12-1 Month Momentum % falls into.
Bon Natural Life (NAS:BON) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -15.94% mean?
Bon Natural Life (BON) has a 12-1 Month Momentum % of -15.94% as of Aug. 22, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Bon Natural Life and its competitors. According to the industry distribution chart, Bon Natural Life ranks #929 out of 1613 companies in the Chemicals industry, placing it in the top 57.6%.
Is Bon Natural Life's 12-1 Month Momentum % too high?
Bon Natural Life's current 12-1 Month Momentum % is -15.94%. Based on the distribution chart, Bon Natural Life ranks #929 out of 1613 companies in the Chemicals industry, which is below the industry midpoint. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's 12-1 Month Momentum % compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #929 out of 1613 companies for 12-1 Month Momentum %. This places Bon Natural Life in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Chemicals company?
A good 12-1 Month Momentum % depends on the Chemicals industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Bon Natural Life and its competitors. Bon Natural Life's current 12-1 Month Momentum % is -15.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.75, compared to a current price of $1.14 — trading 52% above its estimated fair value. The current 12-1 Month Momentum % is -15.94%. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Bon Natural Life (BON), the current 12-1 Month Momentum % is -15.94% as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 52% above its estimated GF Value™ of $0.75.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
12-1 Month Momentum %: -15.94%
GF Value™: $0.75 vs. price of $1.14 (52% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
